Trial Profile
A study of Mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Feb 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 14 Feb 2018 New trial record